Please assess the completion status of the following clinical trial:

Trial Title: Effect of Olopatadine on Allergic Tear Mediators

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Skin test positive~* Able to put drops in eyes~* Able to have tears collected

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Olopatadine (Type: EXPERIMENTAL): one drop in one eye only two times per day at an interval of 6 to 8 hours for 1 week

Based on this trial design, predict the completion outcome and termination type (if applicable).